Stephen L. Silvestro is CCO at OptimizeRx Corp (OPRX). They have made 10 open-market trades across 1 company since 2021, most recently 2026-08-21.
CIK 0001773461
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $50K since 2022, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| OPRX | 262,751 | $2.2M |
Shares reported on the most recent Form 4, priced at the 2026-08-24 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OPRX | SELL | 2025-10-03 | 2025-10-07 | $18.75 | $30K | +8.0% | +4.6% | -27.2% |
| OPRX | BUY | 2022-08-16 | 2022-08-17 | $15.66 | $50K | -1.9% | -6.7% | +38.7% |
| OPRX | SELL | 2021-12-17 | 2021-12-21 | $54.87 | $1.5M | +7.2% | -25.3% | -31.9% |
| OPRX | SELL | 2021-11-17 | 2021-11-19 | $73.98 | $2.0M | -13.8% | -21.7% | -37.7% |
| OPRX | SELL | 2021-10-18 | 2021-10-19 | $85.38 | $2.3M | +7.8% | -19.9% | -47.9% |
| OPRX | SELL | 2021-09-17 | 2021-09-21 | $69.79 | $1.8M | +17.6% | +33.1% | -23.2% |
| OPRX | SELL | 2021-08-17 | 2021-08-19 | $58.41 | $1.5M | +14.7% | +22.9% | +27.0% |
| OPRX | SELL | 2021-07-20 | 2021-07-21 | $50.34 | $1.3M | +1.9% | +8.0% | +64.2% |
| OPRX | SELL | 2021-06-17 | 2021-06-21 | $53.44 | $1.4M | +11.5% | +1.8% | +33.6% |
| OPRX | SELL | 2021-05-17 | 2021-05-19 | $42.72 | $1.1M | +7.8% | +10.1% | +24.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.